SCHEMBL2535243

SCHEMBL2535243

C=CCCCCCCCCC[Mg]Br

nearest known ligand 0.46

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.46
ABCC4 O15439 1/20 0.39
MAPT P10636 1/20 0.39
ALDH1A1 P00352 4/20 0.38
TRPA1 O75762 3/20 0.37
LPAR3 Q9UBY5 2/20 0.34
LMNA P02545 2/20 0.34
LPAR2 Q9HBW0 1/20 0.34
TDP1 Q9NUW8 2/20 0.31
USP2 O75604 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8509889 1.00 TSHR (0.46) TSHRABCC4MAPTALDH1A1TRPA1
SCHEMBL2566885 1.00
SCHEMBL4415425 1.00 TSHR (0.46) TSHRABCC4MAPTALDH1A1TRPA1
SCHEMBL937633 0.97
SCHEMBL232494 0.89
SCHEMBL15272648 0.78 TSHR (0.50) TSHRABCC4MAPTALDH1A1TRPA1
SCHEMBL7525 0.77
SCHEMBL18187344 0.76 TSHR (0.69) TSHRABCC4MAPTALDH1A1TRPA1
SCHEMBL18187333 0.76 TSHR (0.69) TSHRABCC4MAPTALDH1A1TRPA1
SCHEMBL2850911 0.76 TSHR (0.69) TSHRABCC4MAPTALDH1A1TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663548-B2 10-α/β-D-arabinofuranosyl-undecenes as potential anti-mycobacterial agents and process for the preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2017-05-30 US claimed
US-20150259372-A1 10-a/BETA-D-ARABINOFURANOSYL-UNDECENES AS POTENTIAL ANTI-MYCOBACTERIAL AGENTS AND PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-09-17 US claimed
WO-2013038430-A1 SYNTHESIS OF 10-α/β-D-ARABINOFURANOSYL-UNDECENES AS POTENTIAL ANTI-MYCOBACTERIAL AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2013-03-21 WO claimed
US-20260125403-A1 COMPOUND, METHOD FOR MANUFACTURING COMPOUND, COMPOSITION, SURFACE TREATMENT AGENT, ARTICLE, AND METHOD FOR MANUFACTURING ARTICLE AGC Inc. (JP) 2026-05-07 US disclosed
WO-2025077836-A1 IONIZABLE LIPIDS AND LIPID NANOPARTICLES FOR RNA DELIVERY BEIGENE SWITZERLAND GMBH (CH) 2025-04-17 WO disclosed
US-20250034428-A1 COMPOUND, COMPOSITION, SURFACE TREATMENT AGENT, METHOD OF PRODUCING ARTICLE, AND ARTICLE AGC Inc. (JP) 2025-01-30 US disclosed
WO-2024262627-A1 COMPOUND, METHOD FOR PRODUCING COMPOUND, COMPOSITION, SURFACE TREATMENT AGENT, ARTICLE, AND METHOD FOR PRODUCING ARTICLE AGC株式会社 2024-12-26 WO disclosed
US-20240294707-A1 COMPOUND, COMPOSITION, SURFACE TREATMENT AGENT, COATING LIQUID, ARTICLE, AND METHOD FOR PRODUCING ARTICLE AGC Inc. (JP) 2024-09-05 US disclosed
EP-4424745-A1 COMPOUND, COMPOSITION, SURFACE TREATMENT AGENT, COATING LIQUID, ARTICLE, AND METHOD FOR MANUFACTURING ARTICLE AGC INC. (JP) 2024-09-04 EP disclosed
CN-118201985-A Compound, composition, surface treatment agent, coating liquid, article, and method for producing article AGC株式会社 2024-06-14 CN disclosed
WO-2023204020-A1 COMPOUND, COMPOSITION, SURFACE TREATING AGENT, METHOD FOR PRODUCING ARTICLE, AND ARTICLE AGC株式会社 2023-10-26 WO disclosed
EP-2661502-B1 BIOSENSOR FOR DETECTING THE PRESENCE OF PROTEASES AND OPTIONALLY QUANTIFYING THE ENZYMATIC ACTIVITY THEREOF Commissariat à l'énergie atomique et aux énergies alternatives (FR) 2016-03-09 EP disclosed
US-20150259372-A1 10-a/BETA-D-ARABINOFURANOSYL-UNDECENES AS POTENTIAL ANTI-MYCOBACTERIAL AGENTS AND PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-09-17 US disclosed
EP-2661502-A1 BIOSENSOR FOR DETECTING THE PRESENCE OF PROTEASES AND OPTIONALLY QUANTIFYING THE ENZYMATIC ACTIVITY THEREOF Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) 2013-11-13 EP disclosed
WO-2013038430-A1 SYNTHESIS OF 10-α/β-D-ARABINOFURANOSYL-UNDECENES AS POTENTIAL ANTI-MYCOBACTERIAL AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2013-03-21 WO disclosed
WO-2012093162-A1 BIOSENSOR FOR DETECTING THE PRESENCE OF PROTEASES AND OPTIONALLY QUANTIFYING THE ENZYMATIC ACTIVITY THEREOF COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2012-07-12 WO disclosed
US-20110256552-A1 METHOD FOR PREPARING A SUBSTRATE FOR IMMOBILIZING A CELL, SAID SUBSTRATE AND USES THEREOF UNIVERSITE VICTOR SEGALEN BORDEAUX 2 (FR) 2011-10-20 US disclosed
WO-2010000593-A1 BIOCHIPS FOR DETECTING THE ENZYMATIC ACTIVITY OF A PROTEASE ENZYME COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2010-01-07 WO disclosed
EP-2139999-A1 METHOD FOR PREPARING A SUBSTRATE FOR IMMOBILISING A CELL, SAID SUBSTRATE AND USES THEREOF Université Victor Segalen Bordeaux 2 (FR) 2010-01-06 EP disclosed
WO-2008125637-A1 METHOD FOR PREPARING A SUBSTRATE FOR IMMOBILISING A CELL, SAID SUBSTRATE AND USES THEREOF UNIVERSITE VICTOR SEGALEN - BORDEAUX 2 (FR) 2008-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034428-A1 COMPOUND, COMPOSITION, SURFACE TREATMENT AGENT, METHOD OF PRODUCING ARTICLE, AND ARTICLE VCL, SGMS2, KRT18 TSHR 4330/4885ABCC4 4666/4885MAPT 771/4885
US-20150259372-A1 10-a/BETA-D-ARABINOFURANOSYL-UNDECENES AS POTENTIAL ANTI-MYCOBACTERIAL AGENTS AND PROCESS FOR THE PREPARATION THEREOF DCXR, DHPS, MANBA TSHR 3236/4885ABCC4 946/4885MAPT 4045/4885
US-20110256552-A1 METHOD FOR PREPARING A SUBSTRATE FOR IMMOBILIZING A CELL, SAID SUBSTRATE AND USES THEREOF FUS, NEFM, PIGS TSHR 3241/4885ABCC4 3842/4885MAPT 2870/4885
US-20260125403-A1 COMPOUND, METHOD FOR MANUFACTURING COMPOUND, COMPOSITION, SURFACE TREATMENT AGENT, ARTICLE, AND METHOD FOR MANUFACTURING ARTICLE MRE11, C9, MSR1 TSHR 2715/4885ABCC4 2780/4885MAPT 4742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.